Related Experiment Video
Updated: Jan 30, 2026

Electrically Evoked Stapedius Reflex Measurements in Cochlear Implantation and Its Application in the Postoperative Fitting Process
Published on: June 21, 2024
Acute Pump Thrombosis in the Early Postoperative Period After HeartMate 3 Implantation
Jeroen J H Bunge1,2, Corstiaan A den Uil1,2, Alina C Constantinescu1
1From the Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.
Insights
Acute thrombosis in HeartMate 3 continuous-flow left ventricular assist devices is rare. This case highlights early pump and outflow graft thrombosis, likely caused by low-flow episodes and inadequate anticoagulation, requiring device replacement.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Medical Device Technology
Background:
- Continuous-flow left ventricular assist devices (CF-LVADs) are crucial for advanced heart failure management.
- The HeartMate 3 (HM3) is a centrifugal-flow CF-LVAD known for its hemocompatibility and low thrombosis rates.
- Thrombosis remains a significant concern in LVAD therapy, impacting device longevity and patient outcomes.
Observation:
- This report details an unusual case of early-onset thrombosis affecting both the HeartMate 3 pump and its outflow graft.
- The patient experienced symptoms necessitating emergent surgical intervention, including pump explantation and outflow graft revision.
- No prior reports document acute thrombosis of the HeartMate 3 pump itself, excluding thrombus ingestion.
Findings:
- The primary identified causes for this early thrombosis were recurrent episodes of low device flow and suboptimal anticoagulation levels.
- These factors likely contributed to a prothrombotic environment within the device and associated vasculature.
- The case underscores the importance of vigilant monitoring of device performance and anticoagulation in LVAD patients.
Implications:
- This case expands the understanding of potential thrombotic complications associated with the HeartMate 3 LVAD.
- It emphasizes the need for careful management of anticoagulation and device flow parameters to prevent early pump thrombosis.
- Further research into HM3 thrombosis mechanisms and preventative strategies is warranted to optimize patient safety and device efficacy.
Abstract:
There are no reports of acute pump thrombosis in the latest, continuous flow left ventricular assist devices type HeartMate 3, other than thrombus ingestion. We present a case of early thrombosis of the pump and outflow graft, necessitating acute pump and outflow graft replacement. A combination of low-flow episodes and subtherapeutic levels of anticoagulation was the most likely cause.
Related Concept Videos
Periodic Classification of the Elements
The Periodic Table
Venous Thrombosis I: Introduction
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
Pumped Concrete
For direct-acting pumps, the concrete enters the pump via the inlet valve under the action of gravity and suction created by the movement of the piston. This concrete is then forced into the pipeline and out through the outlet valve by the forward movement...

